Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

被引:5
|
作者
Pisu, Salvatore [1 ,2 ]
Caocci, Giovanni [3 ,4 ]
d'Aloja, Ernesto [1 ,2 ]
Efficace, Fabio [5 ]
Vacca, Adriana [4 ]
Piras, Eugenia [4 ]
Orofino, Maria Grazia [6 ]
Addari, Carmen [6 ]
Pintor, Michela [1 ,2 ]
Demontis, Roberto [1 ]
Demuru, Federica [2 ]
Pittau, Maria Rita [1 ]
Collins, Gary S. [7 ]
La Nasa, Giorgio [3 ,4 ]
机构
[1] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy
[2] Univ Cagliari Sardegna Ric, Mediterranean Ctr Clin Bioeth, Cagliari, Italy
[3] Univ Cagliari, Dept Med Sci, Hematol, Cagliari, Italy
[4] Hosp R Binaghi, Bone Marrow Transplantat Ctr, Cagliari, Italy
[5] Data Ctr, Hlth Outcome Res Unit, Grp Italiano Malattie Ematol Adulto GIMEMA, Rome, Italy
[6] Univ Cagliari, Pediat Clin Bone Marrow Transplant Ctr, Dept Biomed Sci & Biotechnol, Cagliari, Italy
[7] Univ Oxford, Ctr Stat Med, Oxford, England
来源
PHILOSOPHY ETHICS AND HUMANITIES IN MEDICINE | 2014年 / 9卷
关键词
Patient-doctor relationship; Communication bias; Conscious consent;
D O I
10.1186/1747-5341-9-13
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Introduction: The informed consent process is the legal embodiment of the fundamental right of the individual to make decisions affecting his or her health., and the patient's permission is a crucial form of respect of freedom and dignity, it becomes extremely important to enhance the patient's understanding and recall of the information given by the physician. This statement acquires additional weight when the medical treatment proposed can potentially be detrimental or even fatal. This is the case of thalassemia patients pertaining to class 3 of the Pesaro classification where Allogenic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative treatment. Unfortunately, this kind of intervention is burdened by an elevated transplantation-related mortality risk (TRM: all deaths considered related to transplantation), equal to 30% according to published reports. In thalassemia, the role of the patient in the informed consent process leading up to HSCT has not been fully investigated. This study investigated the hypothesis that information provided by physicians in the medical scenario of HSCT is not fully understood by patients and that misunderstanding and communication biases may affect the clinical decision-making process. Methods: A questionnaire was either mailed or given personally to 25 patients. A second questionnaire was administered to the 12 physicians attending the patients enrolled in this study. Descriptive statistics were used to evaluate the communication factors. Results: The results pointed out the difference between the risks communicated by physicians and the risks perceived by patients. Besides the study highlighted the mortality risk considered to be acceptable by patients and that considered to be acceptable by physicians. Conclusions: Several solutions have been suggested to reduce the gap between communicated and perceived data. A multi-disciplinary approach may possibly help to attenuate some aspects of communication bias. Several tools have also been proposed to fill or to attenuate the gap between communicated and perceived data. But the most important tool is the ability of the physician to comprehend the right place of conscious consent in the relationship with the patient.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
    Salvatore Pisu
    Giovanni Caocci
    Ernesto d’Aloja
    Fabio Efficace
    Adriana Vacca
    Eugenia Piras
    Maria Grazia Orofino
    Carmen Addari
    Michela Pintor
    Roberto Demontis
    Federica Demuru
    Maria Rita Pittau
    Gary S Collins
    Giorgio La Nasa
    Philosophy, Ethics, and Humanities in Medicine, 9
  • [2] Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
    Giovanni Caocci
    Giorgio La Nasa
    Ernesto d'Aloja
    Adriana Vacca
    Eugenia Piras
    Michela Pintor
    Roberto Demontis
    Salvatore Pisu
    BMC Medical Ethics, 12
  • [3] Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients
    Caocci, Giovanni
    La Nasa, Giorgio
    d'Aloja, Ernesto
    Vacca, Adriana
    Piras, Eugenia
    Pintor, Michela
    Demontis, Roberto
    Pisu, Salvatore
    BMC MEDICAL ETHICS, 2011, 12
  • [4] Unrelated donor stem cell transplantation in adult patients with thalassemia
    La Nasa, G
    Caocci, G
    Argiolu, F
    Giardini, C
    Locatelli, F
    Vacca, A
    Orofino, MG
    Piras, E
    Addari, MC
    Ledda, A
    Contu, L
    BONE MARROW TRANSPLANTATION, 2005, 36 (11) : 971 - 975
  • [5] Unrelated donor stem cell transplantation in adult patients with thalassemia
    G La Nasa
    G Caocci
    F Argiolu
    C Giardini
    F Locatelli
    A Vacca
    M G Orofino
    E Piras
    M C Addari
    A Ledda
    L Contu
    Bone Marrow Transplantation, 2005, 36 : 971 - 975
  • [6] Evolving Selection of Unrelated Donor for Hematopoietic Stem Cell Transplantation for Patients with β Thalassemia
    Tan, Wanxia
    He, Yuelin
    Feng, Xiaoqin
    Wu, Xuedong
    Li, Chunfu
    Liao, Jianyun
    Liu, Xuan
    Liu, Xiaoting
    Ruan, Yongsheng
    Wen, Jianyun
    Ren, Yuqiong
    Pei, Fuyu
    Liu, Qiujun
    BLOOD, 2019, 134
  • [7] Is 'informed consent' an 'understood consent' in hematopoietic cell transplantation?
    D'Souza, A.
    Pasquini, M.
    Spellecy, R.
    BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 10 - 14
  • [8] Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation?
    A D’Souza
    M Pasquini
    R Spellecy
    Bone Marrow Transplantation, 2015, 50 : 10 - 14
  • [9] Hematopoietic stem cell transplantation in thalassemia
    Gaziev, J.
    Sodani, P.
    Lucarelli, G.
    BONE MARROW TRANSPLANTATION, 2008, 42 (Suppl 1) : S41 - S41
  • [10] Hematopoietic stem cell transplantation in thalassemia
    J Gaziev
    P Sodani
    G Lucarelli
    Bone Marrow Transplantation, 2008, 42 : S41 - S41